-transparent.png){kind=logo}
One hundred sixteen children, including 50 less than 10 years of age, received isoniazid therapy for tuberculous infection. Determinations of serum glutamic oxaloacetic transaminase concentrations at time of institution of therapy, 6 to 20 weeks later, and again at the completion of the therapeutic course, showed no evidence of hepatotoxicity. Clinical symptoms were never such that discontinuation of therapy was necessary.
Related Publications
R S Rapp, and
R W Campbell, and
J C Howell, and
E L Kendig
October 1979,
Pediatrics,
R S Rapp, and
R W Campbell, and
J C Howell, and
E L Kendig
February 1984,
Indian pediatrics,
R S Rapp, and
R W Campbell, and
J C Howell, and
E L Kendig
May 1975,
The Journal of pediatrics,
R S Rapp, and
R W Campbell, and
J C Howell, and
E L Kendig
September 1989,
The Pediatric infectious disease journal,
R S Rapp, and
R W Campbell, and
J C Howell, and
E L Kendig
August 1981,
Minerva pediatrica,
R S Rapp, and
R W Campbell, and
J C Howell, and
E L Kendig
February 1995,
The Pediatric infectious disease journal,
R S Rapp, and
R W Campbell, and
J C Howell, and
E L Kendig
April 2021,
Minerva pediatrics,
R S Rapp, and
R W Campbell, and
J C Howell, and
E L Kendig
August 1976,
Pediatrics,
R S Rapp, and
R W Campbell, and
J C Howell, and
E L Kendig
January 1985,
Problemy tuberkuleza,
R S Rapp, and
R W Campbell, and
J C Howell, and
E L Kendig
May 1976,
Medecine & chirurgie digestives,
